 |
|
 |
|
 |
| |
 |
|
Class Information
Number: 530
Name: Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof >
Description:
| Class Number |
Class Name |
No. of Patents | | 530/806 |
Antigenic peptides or proteins |
641 | | 530/800 |
Antihypertensive peptides |
81 | | 530/810 |
Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g., biological cell or cell fragment as carrier, etc. |
241 | | 530/811 |
Peptides or proteins is immobilized on, or in, an inorganic carrier |
194 | | 530/812 |
Peptides or proteins is immobilized on, or in, an organic carrier |
266 | | 530/813 |
Carrier is a saccharide |
159 | | 530/814 |
Cellulose or derivatives thereof |
111 | | 530/815 |
Carrier is a synthetic polymer |
287 | | 530/816 |
Attached to the carrier via a bridging agent |
253 | | 530/817 |
Entrapped within the carrier, e.g., gel, hollow fibre, etc. |
63 | | 530/802 |
Chromogenic or luminescent peptides |
80 | | 530/807 |
Hapten conjugated with peptide or protein |
229 | | 530/868 |
Involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance |
236 | | 530/862 |
Involving ige or igd |
47 | | 530/861 |
Involving igg3, igg4, iga, or igy |
108 | | 530/863 |
Involving igm |
51 | | 530/864 |
Monoclonal |
119 | | 530/865 |
Human |
35 | | 530/866 |
Involving immunoglobulin or antibody fragment, (e.g., f(ab)'2, fab', fab, fv, fc, heavy chain, light chain, etc.) |
234 | | 530/867 |
Involving immunoglobulin or antibody produced via recombinant dna technology |
69 | | 530/500 |
Lignins or derivatives |
115 | | 530/501 |
Aldehyde, ketone or ozone reacted with a lignin or lignin containing substance, or product thereof |
64 | | 530/504 |
Carboxylic acid anhydride, or a compound having halogen bonded directly to acyclic carbon by nonionic bonding, reacted with a lignin or lignin containing substance, or product thereof |
23 | | 530/505 |
Compound containing nitrogen attached directly or indirectly to carbon by nonionic bonding reacted with a lignin or lignin containing substance, or product therof |
32 | | 530/502 |
Compound which includes phenolic hydroxy or oxygen containing hetero ring reacted with a lignin or lignin containing substance, or product thereof |
49 | | 530/506 |
Heavy metal, aluminum, silicon or phosphorus containing |
39 | | 530/503 |
Hydrogenation of a lignin or lignin containing substance, or product thereof |
2 | | 530/507 |
Processes utilizing an organic solvent or a compound having alcoholic hydroxy bonded directly to an acyclic carbon, or product thereof |
40 | | 530/808 |
Materials and products related to genetic engineering or hybrid or fused cell technology, e.g., hybridoma, monoclonal products, etc. |
299 | | 530/809 |
Fused cells, e.g., hybridoma, etc. |
250 | | 530/200 |
Natural resins or derivatives (e.g., wood or pine tar; cativo resin derivatives, etc.) |
34 | | 530/202 |
Cut wood starting material used in process, or product thereof (e.g., using pine stumps, chips, bark, etc., as starting material) |
11 | | 530/203 |
Plant sap or fossil starting material used in process, or product thereof (e.g., using copal, coal, amber, dammar, etc., as starting material) |
10 | | 530/204 |
Pine oleoresin starting material used in process, or product thereof (e.g., using gum turpentine, pine gum, pine resin, etc., as starting material) |
9 | | 530/205 |
Recovery of tall oil or derivatives from papermaking waste, purification of tall oil, or separation of components of tall oil; or product thereof (e.g., separation of rosin, fatty acids, sterols, etc.; decolorizing, etc.) |
41 | | 530/207 |
Esterification used in the process, or product thereof |
9 | | 530/208 |
Inorganic material used in the process, or product thereof (e.g., using sulfuric acid, boric acid, etc.) |
31 | | 530/209 |
Phosphorus or heavy metal containing material, elemental hydrogen, sulfur dioxide, or carbon dioxide used in the process, or product thereof |
11 | | 530/206 |
Organic sulfur or nitrogen containing material used in the process, or product thereof |
11 | | 530/210 |
Rosin or derivative used as starting material in process, or product thereof (e.g., using gum rosin, wood rosin, solid tall oil rosin, etc.) |
56 | | 530/213 |
Boron or phosphorus containing material used in the process, or product thereof |
23 | | 530/214 |
Diels-alder adducts (e.g., of maleic anhydride, fumaric acid, etc., with conjugated dienes, such as rosin acids, terpenes, etc.) |
38 | | 530/215 |
Esterification of rosin or derivative via carboxyl group, or product thereof |
40 | | 530/216 |
Chemical treatment or color modification of esterified rosin or derivative, or product thereof (e.g., partial saponification of rosin triglycerides; removal of color bodies from rosin esters, etc.) |
25 | | 530/217 |
Oxygen containing ring or halogen containing material used in the esterification, or product thereof (e.g., using alkylene oxides, polysaccharides, alkyl halides, etc.) |
27 | | 530/218 |
Polyhydroxy material used in the esterification, or product thereof (e.g., forming ester gum, etc.) |
53 | | 530/226 |
Heat treatment of rosin or derivative in the absence of nonrosin organic reactants, or product thereof (e.g., forming rosin oil; disproportionated, dehydrogenated, or isomerized rosin; etc.) |
11 | | 530/227 |
Metal, halogen, or silicon containing material used in the process, or product thereof (e.g., using clay, zeolites, etc.) |
10 | | 530/223 |
Hydrogenation or product thereof (e.g., forming dihydro rosin acids; rosinyl alcohol or derivatives; etc.) |
12 | | 530/224 |
Metal containing material used to form salts of rosin acids, or product thereof |
13 | | 530/225 |
Alkali metal containing material (i.e., li, na, k, rb or cs) |
7 | | 530/221 |
Nitrogen containing material used in the process, or product thereof |
28 | | 530/222 |
The nitrogen containing material is inorganic |
4 | | 530/211 |
Polymerization or product thereof (e.g., dimer rosin, etc.) |
35 | | 530/212 |
Chemical treatment or color modification of polymerized rosin or derivative, or product thereof (e.g., hydrogenation or esterification of polymerized rosin; removal of color bodies from polymerized rosin, etc.) |
28 | | 530/228 |
Purification process or product thereof |
7 | | 530/229 |
Immiscible solvents used in the process, or product thereof |
2 | | 530/219 |
Sulfur, selenium, or tellurium containing material used in the process, or product thereof (e.g., disproportionation of rosin, etc.) |
17 | | 530/220 |
The sulfur, selenium, or tellurium containing material is inorganic |
10 | | 530/201 |
Shellac containing starting material used in process, or product thereof (e.g., lac, sticklac, seedlac, flake shellac, bleached shellac, etc.) |
10 | | 530/230 |
Tall oil or derivative used as starting material in process, or product thereof (e.g., metal salts of tall oil fatty acids; tall oil pitch, etc.) dehydrogenated, or isomerized rosin; etc.) |
45 | | 530/232 |
Esterification of tall oil acids, or product thereof |
27 | | 530/231 |
Nitrogen containing material used in the process, or product thereof |
17 | | 530/233 |
Sulfur, boron, phosphorus, or iodine containing material used in the process, or product thereof |
17 | | 530/801 |
Peptide sweetners |
57 | | 530/300 |
Peptides of 3 to 100 amino acid residues |
4979 | | 530/327 |
11 to 14 amino acid residues in defined sequence |
1906 | | 530/326 |
15 to 23 amino acid residues in defined sequence |
2337 | | 530/325 |
24 amino acid residues in defined sequence |
1000 | | 530/324 |
25 or more amino acid residues in defined sequence |
3638 | | 530/330 |
4 to 5 amino acid residues in defined sequence |
1740 | | 530/329 |
6 to 7 amino acid residues in defined sequence |
1586 | | 530/328 |
8 to 10 amino acid residues in defined sequence |
2190 | | 530/316 |
Angiotensin; related peptides |
61 | | 530/314 |
Bradykinin; kallidin; related peptides |
66 | | 530/307 |
Calcitonin; related peptides |
179 | | 530/345 |
Chemical aftertreatment, e.g., acylation, methylation, etc. |
859 | | 530/332 |
Containing at least one abnormal peptide link, e.g., gamma peptide bonded, etc. |
316 | | 530/306 |
Corticotropin (atch); related peptides |
59 | | 530/317 |
Cyclic peptides |
1199 | | 530/320 |
Bacitracin; related peptides |
32 | | 530/321 |
Containing only normal peptide links in the ring, i.e., homodetic cyclic peptides |
203 | | 530/318 |
The cyclisation occurring through the 4-amino radical of 2,4-diamino butanoic acid |
49 | | 530/319 |
Polymyxin; related peptides |
22 | | 530/302 |
Endorphin and enkephalin; related peptides |
177 | | 530/308 |
Glucagon; related peptides |
145 | | 530/310 |
Gramicidin or tyrocidin; related peptides |
8 | | 530/303 |
Insulin; related peptides |
485 | | 530/305 |
Isolation or purification |
96 | | 530/304 |
Metal complexes, e.g., zn-insulin, etc. |
92 | | 530/313 |
Lutenizing hormone releasing factor (lrf); related peptides |
264 | | 530/312 |
Melanotropin (msh) or eledoisin; related peptides |
38 | | 530/315 |
Oxytocin; vasopressin; related peptides |
91 | | 530/322 |
Peptides containing saccharide radicals, e.g., bleomycins, etc. |
519 | | 530/323 |
Peptides with at least one nonpeptide bond other than a disulfide bond joining two or more sequences of amino acid residues, e.g., homomeric heterodectic peptide other than cyclic disulfide, depsipeptides, etc. |
393 | | 530/309 |
Secretin or gastrin; related peptides |
48 | | 530/344 |
Separation or purification |
456 | | 530/311 |
Somatostatin (srif); related peptides |
269 | | 530/333 |
Synthesis of peptides |
723 | | 530/343 |
By hydrolysis |
81 | | 530/334 |
Polymer supported synthesis, e.g., solid phase synthesis, merrifield synthesis, etc. |
589 | | 530/335 |
Protecting or removing protective groups, e.g., carboxyl group protection, etc. |
221 | | 530/337 |
Of amino group |
146 | | 530/336 |
Of side chain or sulfur containing group |
127 | | 530/338 |
Solution phase synthesis |
189 | | 530/342 |
Mixed anhydride synthesis |
25 | | 530/339 |
Segment condensation, e.g., ugi condensation, etc. |
76 | | 530/340 |
With phosphorus containing material |
29 | | 530/341 |
With use of carbonimide or imidiazole |
27 | | 530/301 |
Thymopoietin or lipotropin; related peptides |
42 | | 530/331 |
Tripeptides, e.g., tripeptide thyroliberin (trh), melanostatin (mif), etc. |
1473 | | 530/855 |
Proteins from animals other than mammals or birds |
64 | | 530/857 |
Fish; fish eggs; shell fish; crustacea |
83 | | 530/858 |
Insects; venom |
75 | | 530/856 |
Snakes; venom |
35 | | 530/827 |
Proteins from mammals or birds |
132 | | 530/829 |
Blood |
243 | | 530/830 |
Plasma; serum |
347 | | 530/831 |
Cohn fractions |
86 | | 530/840 |
Bones; tendons; teeth; cartilage |
109 | | 530/828 |
Cancer |
262 | | 530/843 |
Digestive system |
10 | | 530/847 |
Bile |
1 | | 530/846 |
Liver |
25 | | 530/845 |
Pancreas |
15 | | 530/844 |
Stomach; intestine |
14 | | 530/849 |
Eyes; vessels; umbilical cord |
12 | | 530/854 |
Glands |
49 | | 530/848 |
Lungs |
25 | | 530/837 |
Lymph; lymph-glands; thymus |
45 | | 530/838 |
Marrow; spleen |
30 | | 530/832 |
Milk; colostrum |
96 | | 530/836 |
Mucus; mucous glands; bursa; arthral fluid; spinal fluid |
6 | | 530/841 |
Muscles; heart |
34 | | 530/839 |
Nerves; brain |
73 | | 530/850 |
Reproductive organs or embryos |
47 | | 530/851 |
Placenta; amniotic fluid |
83 | | 530/852 |
Sperm |
22 | | 530/853 |
Ovary; eggs; embryos |
57 | | 530/842 |
Skin; hair; nails; sebaceous glands; cerumen |
43 | | 530/834 |
Urine; urinary system |
48 | | 530/835 |
Kidney |
22 | | 530/833 |
Whey; cheese |
92 | | 530/820 |
Proteins from micro-organisms |
158 | | 530/825 |
Bacteria |
544 | | 530/823 |
Lower fungi, e.g., mold, etc. |
36 | | 530/824 |
Yeasts |
76 | | 530/822 |
Protozoa |
64 | | 530/821 |
Separation of nucleic acid |
34 | | 530/826 |
Viruses |
277 | | 530/350 |
Proteins, i.e., more than 100 amino acid residues |
13520 | | 530/362 |
Albumin |
237 | | 530/365 |
Lactalbumin, e.g., milk source, etc. |
62 | | 530/366 |
Separation, purification or synthesis |
67 | | 530/367 |
Ovalalbumin, e.g., avidin, conalbumins, etc. |
75 | | 530/368 |
Separation, purification or synthesis |
16 | | 530/369 |
Separation, purification or synthesis |
28 | | 530/363 |
Serum albumin, e.g., bsa, hsa, etc. |
452 | | 530/364 |
Separation, purification or synthesis |
168 | | 530/380 |
Blood proteins or globulins, e.g., proteoglycans, platelet factor 4, thyroglobulin, thyroxine, etc. |
961 | | 530/381 |
Blood coagulation factors and fibrin, e.g., thromboplastin, etc. |
467 | | 530/384 |
Blood coagulation factor ii or factor ii + vii + ix + x, i.e., prothrombin complex or factor |
262 | | 530/383 |
Blood coagulation factor viii, ahf |
386 | | 530/382 |
Fibrin or fibrin intermediates, e.g., fibrinogen, etc. |
291 | | 530/386 |
Globulins |
220 | | 530/392 |
Alpha globulins, e.g., ceruloplastin, haptoglobins, etc. |
97 | | 530/393 |
Antithrombin iii |
53 | | 530/394 |
Beta globulins, e.g., transferrin, etc. |
95 | | 530/387.1 |
Immunoglobulin, antibody, or fragment thereof, other than immunoglobulin antibody, or fragment thereof that is conjugated or absorbed |
2947 | | 530/387.2 |
Anti-idiotypic |
203 | | 530/387.7 |
Binds expression product of cancer-related gene or fragment thereof (e.g., oncogene, proto-oncogene, etc.) |
564 | | 530/387.5 |
Binds oligosaccharide structure |
188 | | 530/387.9 |
Binds specifically-identified amino acid sequence |
1423 | | 530/387.3 |
Chimeric, mutated, or recombined hybrid (e.g., bifunctional, bispecific, rodent-human chimeric, single chain, rfv, immunoglobulin fusion protein, etc.) |
2008 | | 530/388.1 |
Monoclonal |
2173 | | 530/388.9 |
Binds drug, hapten, hapten--carrier complex, or specifically-identified chemical structure (e.g., theophylline, digoxin, etc.) |
282 | | 530/388.2 |
Binds microorganism or normal or mutant component or product thereof (e.g., animal cell, cell-surface antigen, secretory product, etc.) |
890 | | 530/388.4 |
Binds bacterium or similar microorganism or component or product thereof (e.g., stretococcus, legionella, mycoplasma, bacterium-associated antigen, exotoxin, etc.) |
297 | | 530/388.8 |
Binds cancer cell or component or product thereof (e.g., cell-surface antigen, etc.) |
739 | | 530/388.85 |
Binds antigen characterized by name or molecular weight (e.g., cea, nca, cc glycoprotein, melanoma gp 150 antigen, etc.) |
705 | | 530/388.26 |
Binds enzyme |
317 | | 530/388.5 |
Binds fungus or plant cell or component or product thereof (e.g., fungus-associated antigen, etc.) |
65 | | 530/388.7 |
Binds hematopoietic cell or component or product thereof (e.g., erythrocyte granulocyte, macrophage, monocyte, platelet, myelogenous leukemia cell, bone marrow stem cell, granulocytic cell-surface antigen, hemoglobin, thrombospondin, glycophorin, etc.) |
458 | | 530/388.73 |
Binds lymphocytic or lymphocytic-like cell or component or product thereof (e.g., b cell, b-lineage bone marrow cell, null cell, natural killer cell, b-lymphoblastoid cell, b-lineage acute lymphoblastic leukemia cell, b-lymphocytic cell-surface antigen, etc.) |
384 | | 530/388.75 |
Binds t-lymphocytic cell or component or product thereof (e.g., t cell, thymocyte, t-lineage bone marrow cell, t-lymphoblastoid cell, t-lineage acute lymphoblastic leukemia cell, t-lymphocytic cell-surface antigen, etc.) |
389 | | 530/388.24 |
Binds hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, or neurotransmitter (e.g., insulin, human chorionic gonadotropin, intragonadal regulatory protein, mullerian inhibiting substance, inhibin, epidermal growth factor, nerve growth factor, dopamine, norepinephrine, etc.) |
391 | | 530/388.23 |
Binds lymphokine, cytokine, or other secreted growth regulatory factor, differentiation factor, or intercellular mediator specific for a hematopoietic cell (e.g., interleukin, interferon, erythropoietin, etc.) |
509 | | 530/388.21 |
Binds nucleic acid or derivative or component thereof (e.g., dna, rna, dna-rna hybrid, nucleotide, nucleoside, carcinogen-dna adduct, etc.) |
61 | | 530/388.6 |
Binds parasitic protozoan or metazoan cell or component or product thereof (e.g., dirofilaria, eimeria, coccidia, trichinella, parasite cell-surface antigen, etc.) |
112 | | 530/388.25 |
Binds plasma protein, serum protein, or fibrin (e.g., clotting factor, fibrinolytic factor, complement factor, immunoglobulin, apolipoprotein, etc.) |
426 | | 530/388.22 |
Binds receptor (e.g., transferrin receptor, fc receptor, dihydropyridine receptor, il-2 receptor, etc.) |
1071 | | 530/388.3 |
Binds virus or component or product thereof (e.g., virus-associated antigen, etc.) |
261 | | 530/388.35 |
Binds retrovirus or component or product thereof (e.g., hiv, lav, htlv, etc.) |
175 | | 530/388.15 |
Human |
580 | | 530/389.1 |
Polyclonal antibody or immunogloblin of identified binding specificity |
966 | | 530/389.5 |
Binds bacterium or similar microorganism or component or product thereof (e.g., pseudomonas, chlamydia, clostridium, bacterium-associated antigen, etc.) |
204 | | 530/389.7 |
Binds cancer cell or component or product thereof (e.g., cell-surface antigen, etc.) |
342 | | 530/389.8 |
Binds drug, hapten, hapten-carrier complex, or specifically-identified chemical structure (e.g., theophylline, digoxin, etc.) |
346 | | 530/389.6 |
Binds hematopoietic cell or component or product thereof (e.g., erythrocyte, granulocyte, bone marrow cell, lymphocyte, leukemic cell, hematopoietic cell-surface antigen, hemoglobin, etc.) |
213 | | 530/389.2 |
Binds hormone, lymphokine, cytokine, or other secreted growth regulatory factor, differentiation factor, intercellular mediator, or neurotransmitter (e.g., insulin, human chorionic gonadotropin, glucagon, cardiodilatin, interleukin, interferon, norepinephrine, epinephrine, acetylcholine, etc.) |
467 | | 530/389.3 |
Binds plasma protein, serum protein, or fibrin (e.g., clotting factor, fibrinolytic factor, complement factor, immunoglobulin, apolipoprotein, etc.) |
274 | | 530/389.4 |
Binds virus or component or product thereof (e.g., virus-associated antigen, etc.) |
220 | | 530/390.1 |
Removing or inactivating virus or bacterium or component or product thereof (e.g., endotoxin, etc.) |
107 | | 530/390.5 |
Removing, dissociating, or preventing the formation of aggregated, denatured, fragmented, or polymerized immunoglobulin or antibody; or preventing or reducing complement fixation or binding; or reducing antigenicity; or removing, inactivating, or inhibiting contaminating plasma proteins (e.g., proteolytic enzymes, etc.) |
126 | | 530/391.1 |
Monoclonal or polyclonal antibody or immunoglobulin or fragment thereof that is conjugated or adsorbed (e.g., adsorbed to a solid support, etc.) |
879 | | 530/391.7 |
Conjugated to a cytotoxic agent, drug, or other biologically-active substance |
623 | | 530/391.9 |
Conjugated via a specifically-identified linking group, coupling agent, or conjugation agent |
299 | | 530/391.3 |
Conjugated to a detectable label or radioisotope or radionuclide or heavy metal-containing compound |
1022 | | 530/391.5 |
Conjugated via a specifically-identified linking group, chelating group, coordination complex, coupling agent, or conjugation agent |
393 | | 530/385 |
Hemoglobins or globins |
415 | | 530/360 |
Casein or caseinate |
126 | | 530/361 |
Separation, purification or synthesis |
70 | | 530/402 |
Chemical modification or the reaction product thereof, e.g., covalent attachment or coupling, etc. |
1746 | | 530/407 |
Hydrolysis of protein |
133 | | 530/409 |
Nitrogen containing reactant |
498 | | 530/410 |
Oxygen containing reactant |
330 | | 530/411 |
Oxygen containing is saccharide |
84 | | 530/403 |
Protein is identified as an antigen, e.g., immunogenic carriers, etc. |
848 | | 530/405 |
Nitrogen containing reactant |
584 | | 530/406 |
Oxygen containing reactant |
282 | | 530/404 |
Sulfur containing reactant |
322 | | 530/408 |
Sulfur containing reactant |
353 | | 530/395 |
Glycoprotein, e.g., mucins proteoglycans, etc. |
1647 | | 530/397 |
Glycoprotein hormones |
321 | | 530/398 |
Gonadatropins |
130 | | 530/396 |
Lectins, e.g., concanavalin, hemagglutinin, etc. |
136 | | 530/399 |
Hormones, e.g., prolactin, thymosin, growth factors, etc. |
1782 | | 530/359 |
Lipoproteins, e.g., egg yolk proteins, cylomicrons, etc. |
184 | | 530/351 |
Lymphokines, e.g., interferons, interlukins, etc. |
2191 | | 530/400 |
Metal containing, e.g., chromoproteins, ferritin, ferredoxins, etc. |
185 | | 530/401 |
Cytochromes, e.g., chlorophyl, orgotein, etc. |
37 | | 530/358 |
Nucleoproteins, e.g., chromatin, chromosomal proteins, histones, protamines, salmine, etc. |
220 | | 530/352 |
Phosphoproteins, e.g., phosvitin, vitellogenin, etc. |
128 | | 530/370 |
Plant proteins, e.g., derived from legumes, algae or lichens, etc. |
742 | | 530/371 |
Derived from fungi, e.g., yeasts, mushroom, etc. |
128 | | 530/372 |
Derived from grain, e.g., prolamines, etc. |
106 | | 530/376 |
Derived from corn |
68 | | 530/375 |
Derived from wheat |
76 | | 530/374 |
Gluten or gliadin |
74 | | 530/373 |
Zein |
32 | | 530/379 |
Derived from leafy green plants, e.g., alfalfa pollen, etc. |
128 | | 530/377 |
Derived from oil seed, e.g., cotton seed, rapeseed, sunflower, etc. |
180 | | 530/378 |
Derived from soybean |
238 | | 530/353 |
Scleroproteins, e.g., fibroin, elastin, silk, etc. |
118 | | 530/356 |
Collagen |
542 | | 530/354 |
Gelatin |
222 | | 530/355 |
Separation, purification or synthesis |
84 | | 530/357 |
Keratin |
82 | | 530/412 |
Separation or purification |
1378 | | 530/413 |
Immunological separation or affinity chromatography |
1133 | | 530/427 |
Physical treatment |
321 | | 530/418 |
Precipitation |
288 | | 530/419 |
With added material |
222 | | 530/420 |
Inorganic |
201 | | 530/421 |
Polymeric, e.g., polyethylene glycol, etc. |
124 | | 530/415 |
Selective absorbtion, e.g., ca phosphate sorbents, etc. |
338 | | 530/417 |
Chromatography or by septum selective as to material, e.g., gel filtration, molecular sieve dialysis, etc. |
761 | | 530/416 |
Ion exchange |
641 | | 530/422 |
Solvent extraction |
205 | | 530/426 |
Hydrocarbon or halogenated hydrocarbon |
27 | | 530/423 |
Oxygenated material |
68 | | 530/424 |
Alcohol |
81 | | 530/425 |
Carboxyl containing |
39 | | 530/414 |
Ultra filtration or osmosis |
273 | | 530/860 |
Renin inhibitors |
134 | | 530/859 |
Waste, waste material, refuse or sludge, e.g., effluents, fecal matter, etc. |
40 | |
|
|
 |
|
 |
|
| |
Randomly Featured Patents |
|
| ©
2006. PatentGenius. All Rights Reserved. |
|
|